Evidence map›Paper›PMID 25143472›Full record

ArticleJournal of molecular endocrinology2014

Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells.

Jason F Ohlstein, Amy L Strong, John A McLachlan, Jeffrey M Gimble, Matthew E Burow, Bruce A Bunnell

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 125 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jason F OhlsteinCenter for Stem Cell Research and Regenerative MedicineTulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, Louisiana 70112, USASection of Hematology and Medical OncologyDepartment of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USADepartment of PharmacologyTulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Amy L StrongCenter for Stem Cell Research and Regenerative MedicineTulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, Louisiana 70112, USASection of Hematology and Medical OncologyDepartment of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USADepartment of PharmacologyTulane University School of Medicine, New Orleans, Louisiana 70112, USA.
John A McLachlanCenter for Stem Cell Research and Regenerative MedicineTulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, Louisiana 70112, USASection of Hematology and Medical OncologyDepartment of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USADepartment of PharmacologyTulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Jeffrey M GimbleCenter for Stem Cell Research and Regenerative MedicineTulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, Louisiana 70112, USASection of Hematology and Medical OncologyDepartment of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USADepartment of PharmacologyTulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Matthew E BurowCenter for Stem Cell Research and Regenerative MedicineTulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, Louisiana 70112, USASection of Hematology and Medical OncologyDepartment of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USADepartment of PharmacologyTulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Bruce A BunnellCenter for Stem Cell Research and Regenerative MedicineTulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, Louisiana 70112, USASection of Hematology and Medical OncologyDepartment of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USADepartment of PharmacologyTulane University School of Medicine, New Orleans, Louisiana 70112, USA Center for Stem Cell Research and Regenerative MedicineTulane University School of Medicine, 1430 Tulane Avenue, SL-99, New Orleans, Louisiana 70112, USASection of Hematology and Medical OncologyDepartment of Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana 70112, USADepartment of PharmacologyTulane University School of Medicine, New Orleans, Louisiana 70112, USA bbunnell@tulane.edu.
Tulane University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 1985 to 2011
$100.1M
NCRR NIH HHS P51 RR000164NIH HHS P51 OD011104
6 · The paper itself

Abstract

Exposure of humans to the endocrine disrupter bisphenol A (BPA) has been associated with increased weight and obesity. However, the mechanism(s) by which BPA increases adipose tissue in humans remains to be determined. The goal of this study was to determine the effects of BPA on adipogenesis of cultured human adipose stromal/stem cells (ASCs), precursors to mature adipocytes. ASCs from three donors were cultured for either 14 or 21 days in adipogenic differentiation media containing increasing concentrations of BPA (100 pM-10 μM). The extent of adipogenic differentiation in the ASCs was assessed by staining with Oil Red O to visualize adipogenic differentiation and then quantified by extraction and optical density measurement of the retained dye. BPA significantly enhanced adipogenesis at a concentration of 1 μM after 21 days of culture. Additionally, we found that BPA increased transcription of the estrogen receptor (ER (ESR1)) and that treatment with the ER antagonist ICI 182 780, blocked the effects of BPA, indicating that BPA may act via an ER-mediated pathway. The results of molecular analyses indicated that the expression of the adipogenesis-associated genes dual leucine zipper-bearing kinase (DLK (MAP3K12)), IGF1, CCAAT/enhancer-binding protein alpha (C/EBPα (CEBPA)), peroxisome proliferator-activated receptor gamma (PPARγ (PPARG)), and lipoprotein lipase (LPL) was temporally accelerated and increased by BPA. In summary, these results indicate that BPA significantly enhances adipogenesis in ASCs through an ER-mediated pathway at physiologically relevant concentrations.

Indexed as

AdipocytesAdipogenesisAdipose TissueAdultAdult Stem CellsBenzhydryl CompoundsBisphenol A CompoundsCell DifferentiationCells, CulturedFemaleHumansMiddle AgedPhenolsStromal CellsUp-RegulationBenzhydryl Compoundsbisphenol ABisphenol A CompoundsPhenolsadipogenesisadipose stromal/stem cellbisphenol A (BPA)endocrine disruptersestrogen receptor

Identifiers

PMID25143472
PMCPMC4757902
OpenAlexW2104276917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.